Here's What Analysts Think of AJG.

Arthur J. Gallagher & Co. stock is trading -9.04% below its average target price of $211.14 after dropping -2.6% during today's afternoon session. Analysts are giving the large-cap Insurance Brokers company an average rating of buy and target prices ranging from $160 to $225 per share.

The stock has a very low short interest at 0.6%, and a short ratio of 1.5. The company's insiders own 0.95% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 87.3% of Arthur J. Gallagher & Co.'s shares being owned by this investor type.

Institutions Invested in Arthur J. Gallagher & Co.

Holder Shares Date Reported Percentage Value
Vanguard Group, Inc. (The) 25,783,678 2022-09-29 12% $4,951,626,394
Blackrock Inc. 16,305,440 2022-09-29 8% $3,131,378,194
FMR, LLC 10,263,992 2022-09-29 5% $1,971,148,324
Capital International Investors 9,785,433 2022-09-29 5% $1,879,243,462
State Street Corporation 9,088,297 2022-09-29 4% $1,745,361,980
Norges Bank Investment Management 6,911,540 2021-12-30 3% $1,327,326,686
JP Morgan Chase & Company 6,822,145 2022-09-29 3% $1,310,158,824
Baillie Gifford and Company 5,567,272 2022-12-30 3% $1,069,166,741
Massachusetts Financial Services Co. 5,534,252 2022-09-29 3% $1,062,825,415
Geode Capital Management, LLC 4,468,650 2022-09-29 2% $858,181,881
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.